Suhalika Sahni (@suhalikapath) header
Suhalika Sahni (@suhalikapath) profile picture

Cytopathology Fellow at UT Health San Antonio | AP/CP Pathologist | Interested in Digital Pathology, AI in Diagnostics, and Clinical Workflow Innovation

San Antonio, TX
Joined June 2021
Photo by Suhalika Sahni (@suhalikapath)Photo by Suhalika Sahni (@suhalikapath)Photo by Suhalika Sahni (@suhalikapath)Photo by Suhalika Sahni (@suhalikapath)Photo by Suhalika Sahni (@suhalikapath)Photo by Suhalika Sahni (@suhalikapath)Photo by Suhalika Sahni (@suhalikapath)Photo by Suhalika Sahni (@suhalikapath)Photo by Suhalika Sahni (@suhalikapath)Photo by Suhalika Sahni (@suhalikapath)
Suhalika Sahni retweeted
🔬 Folliculin mutated renal tumor: H&E & GPNMB IHC Want to sharpen your GU pathology expertise? Join Johns Hopkins faculty for Contemporary Issues in GU Pathology: What Every Pathologist Should Know, Feb 5–7, 2027. Online CME/MOC with updates on WHO classifications.
2
28
55
2,548
Interactive Online Course (2027): Basics in Dermatopathology: the principles of dermatopathological diagnosis and demonstration of educational cases via Zoom with live discussion. Access to over 400 annotated digital slides. Fee: 290E pathologie-dgp.de/pathologie…
7
16
1,381
Suhalika Sahni retweeted
Grateful for this recognition and honored to be named among the 50 on the Power List: Leading Voices by @pathologistmag. A privilege to be included alongside so many inspiring pathologists and trainees who continue to shape and advance our field. thepathologist.com/power-lis…
8
6
2
61
4,188
🧠 Staging pearl: Endometrial carcinomas may appear to invade >50% of the myometrium when tumor extends toward the outer myometrium along a prior cesarean-section scar. The key is to distinguish true deep myometrial invasion from tumor involving or tracking through scarred/thinned myometrium; presence of benign glands tracking underneath the tumor (as seen in this case) is helpful! #GynPath #Pathology #EndometrialCancer #GynecologicPathology
1
5
1
21
1,059
Gall bladder #pathology
3
6
1
25
1,809
Suhalika Sahni retweeted
Core biopsy done for 1 cm mass in 65/F with and clinical impression is papilloma. How should we sign this case out? #breastpath
1
7
45
2,795
Suhalika Sahni retweeted
Thick streaky colloid in a papillary thyroid carcinoma. (Thyroid, FNA)
26
79
1,840
Announcing a free @ISGynP sponsored live virtual webinar on 09/03 @ 12 noon US ET "HRD Testing in Clinical Practice: Recommendations, Best Practices, and Considerations for Molecular Laboratories" by Dr. Hsiao. Register now at isgyp.ca #gynpath #pathtwitter
7
15
980
Can you get this BOGO deal? 👀 Four distinct lesions in one person. Name the lesions...and the genetic association that ties them all together! #PathX #PathQuiz #BreastPath #GIPath #dermpath #ABPath
3
20
1
53
2,775
Suhalika Sahni retweeted
Textbook cytomorphology of Hepatocellular Carcinoma, Fibrolamellar type in a teenage boy, with malignant cells presenting a sharp contrast with the trapped biliary epithelium. (Liver, FNA)
4
30
108
2,800
2026-27 schedule for IRAP and lectures starting next month
1
5
17
1,841
Suhalika Sahni retweeted
Happy Friday! I just received my advance copy of the 5th Edition of Urologic Surgical Pathology! I am deeply grateful to all of our contributors for generously sharing their knowledge, expertise, and time in making this new edition possible.  The book is now available for pre-order:  amazon.com/Urologic-Surgical…
1
11
40
2,596
My latest ASCO Connection article is out, sharing key insights from @ASCOTECAG panel I had the opportunity to moderate on careers in government and industry, featuring perspectives from @Jbauml @mariagjMD and Nicholas Tschernia MD. For oncologists exploring paths beyond traditional clinical practice, I hope these perspectives are useful. connection.asco.org/do/caree… #ASCOConnection #ASCO
5
18
1,672
📢 Join the ISGyP 2026 Annual Meeting! 🌍 “GYN Pathology Here, There, Today and Tomorrow” 📅 7–8 November 2026 💻 Free and fully virtual Connect with colleagues from around the world. Register: isgyp.ca/ #ISGyP2026 #GynPath #Pathology
11
21
1,311
Announcing a free @ISGynP sponsored live virtual slide session on August 13 @ 12 noon US ET by Dr. Dehghani - "Interesting Adnexal/Para Adnexal Tumors". Register now @ isgyp.ca #gynpath #gynaepath #PathTwitter
8
19
1,584
Suhalika Sahni retweeted
“Despite low procedural toxicity, 30-day mortality was 11.1% (108 patients)” A little unfair that these data are published as an 800 word research letter with no additional information about who these patients with early mortality were. Most of these patients are receiving histotripsy in a random fashion without a formal protocol in place. The concern isn’t just the glaring lack of robust efficacy data, the more pressing issue here is the lack of safety data (especially for a procedure that is being marketed as “non-invasive”). jamanetwork.com/journals/jam…
4
14
1,269
Suhalika Sahni retweeted
📣Excited to share our recent article on the practical approach to gastric lesions; the background mucosa & new nomenclatures! Deeply grateful to Dr. Elizabeth Montgomery for her incredible support, mentorship & guidance. diagnostichistopathology.co.… @LizMontgomeryMD #PathX #GIPath
10
36
1
131
7,465
Suhalika Sahni retweeted
Big congratulations to Drs. Kamat, Hensley , and IBCG team! Phenomenal resource! And honored to be part of the study.
Just released in @NatRevUrol : Integrating clinically actionable biomarkers into bladder cancer care : recommendations from the International Bladder Cancer Group @IBCG_BladderCA During our deliberations, one theme was clear: biomarkers don't improve care simply because they're "novel or new" They improve care when they're validated, reproducible, and actually change clinical decisions 🧵 @pjhensley11 @jteoh_hk @UrogerliMD @shilpaonc @LauraBukavinaMD @mouwlab @AndreaNecchi @niyatilobo @Agarwal_CaB @LiangChengMD @karima_oualla @drtanws @MaxKates @BrigidaMaiorano @h_alahmadie @TomFlaigMD @AmirHorowitz @WesKassouf @djmcconkey @JanetKukreja @LAUrology_NL @carme_mir1 @UroMoschini @BogdanaSchmidt @VigneshPackiam
2
5
24
3,960
Suhalika Sahni retweeted
Pleased to share our latest work, published today in @ESMO_Open 👇 As HER-targeted ADCs continue to evolve, understanding HER1–HER4 co-expression may help inform future drug development and patient selection. sciencedirect.com/science/ar… @OncoAlert 🧵Key findings:
9
26
2
64
14,491